Hong Kong PR

APEL's interactive exhibition at Osaka's Knowledge Capital is running now until the end of December 2025.HONG KONG, Mar 10, 2025 - (ACN Newswire via SeaPRwire.com) - As the Expo 2025 Osaka, Kansai, Japan (hereinafter referred to as the "Expo") unfolds, Absolute Pure EnviroSci Limited (hereinafter referred to as "APEL" or the "Company"), an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited (stock code: 1662.HK), proudly launches its ambitious plans aimed at redefining health and sustainability in Japan. In alignment with the Osaka Expo's theme, "Designing Future Society for Our Lives," APEL's initiatives demonstrate its strong commitment to addressing urgent global challenges related to human and ecological well-being.APEL's Vision: Revolutionizing Healthcare, Environmental, and Pet Wellness Sectors with Science and SustainabilityAt the heart of APEL's mission lies a commitment to tackle global challenges through innovation. The Company's mission serves as a strategic roadmap to deploy solutions across healthcare, environmental, and pet wellness sectors. APEL's interactive exhibition at Osaka's Knowledge Capital, running from now until the end of December 2025, along with the Expo, will serve as a dynamic platform to attract visitors from around the world, showcasing its pioneering technologies, engaging stakeholders, and forging alliances that accelerate positive impact.Mr. Jackin Jim (third from the right), Chairman of Yee Hop HoldingsLimited (Stock code: 1662.HK), Dr. Pat Yeung (second from the right),Director of APEL, and Dr. David Chung (first from the right),Chairman of APEL, are pictured with seminar guests.APEL's Expert Seminar: Biomedical Technology Innovation in Osaka.Ambition in Action: APEL's Revolutionary Product LineupAPEL's trio of flagship innovations-WisepuraTM, GERMAGICTM, and GERMAGICTM PET-are engineered to address Japan's pressing needs with precision and scalability:1.WisepuraTM: Redefining Public Health StandardsDeveloped with the Hong Kong University of Science and Technology (HKUST), WisepuraTM combats antimicrobial resistance and environmental hazards:- WisepuraTM Aquapura: A long-lasting antimicrobial material targeting odor elimination and water safety. - Target to deploy in 100+ public facilities by October 2025, reducing waterborne pathogens up to 99%.- WisepuraTM Airpura: An antimicrobial coating for air purification. - Target to partner with 15+ Japanese smart cities to cut airborne infections in transit systems.2. GERMAGICTM: Enhancing Hygiene for Every EnvironmentPowered by Multilevel Antimicrobial Polymer (MAP-1)-certified by 20+ global institutions GERMAGICTM is set to disrupt Japan's JPY 500 billion hygiene market:- Aircraft Air Purification: Partnering with a leading Japanese airline to equip 200+ planes with MAP-1 by Q4 2025, slashing in-flight germ transmission up to 60%.- Smart Building Integration: Collaborating with Techno Frontier Co., Ltd. to integrate MAP-1 into eco-friendly construction materials, targeting 30% energy savings in HVAC systems.3.GERMAGICTM PET: Elevating Human-Animal SymbiosisAPEL's tech-driven pet care brand merges diagnostics with antimicrobial solutions: - Target to capture 10% of Japan's JPY 1.2 trillion pet market by 2026, reducing pet-related allergies up to 50% in urban households. - Innovation: Launching pet wellness hubs in Tokyo and Osaka, offering real-time health monitoring for 50,000+ pets.APEL's flagship innovations-WisepuraTM, GERMAGICTM, and GERMAGICTM PET.Unwavering Confidence: Japan's Leaders Rally Behind APELOn 6 March 2025, APEL hosted the Expert Seminar, marking a watershed moment for the company and bringing together Japan's corporate, academic, and governmental elites such as Mr. Takuya Nomura, General Producer of Knowledge Capital, Mr. Ricky Fong, Director of Hong Kong Trade Development Council (HKTDC) Osaka Office, Mr. Ryoji Furukawa, Executive Secretary of Keizai Doyukai (Japan Association of Corporate Executives), Professor Shinji Maegawa from Kyoto University, Dr. Christine Yuan Huang, CEO & Founder of Quantum Life Limited, Mr. Kawahara Toshikazu, President of Techno Frontier Co. Ltd., Mr. German Cheung, Founder of Market Trend Interactive Solution Limited, and Mr. Neo Zhong, General Manager of Shanghai GermagicTM.A Roadmap to Transformative ImpactDr. David Chung, Chairman of APEL, stated, "In our relentless pursuit to tackle global challenges, we are committed to transforming scientific research into impactful applications that enhance the quality of life and living environments. It is a tremendous honor to receive strong endorsements from various sectors in Japan at this Seminar, signaling an exciting new chapter for APEL as we expand our health and environmental innovations globally. As we enter the Japanese market, we look forward to collaborating with local researchers, institutions, and businesses to develop cutting-edge solutions that address pressing global issues, paving the way for a brighter future for all."With the grand exhibition and expert seminar, APEL is confident that its innovations will deliver significant benefits, enhancing health and well-being while fostering a sustainable future. The anticipation surrounding these developments reflects APEL's commitment to excellence and its vision for a healthier world.About APELAbsolute Pure EnviroSci Limited (APEL), an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 1662.HK), with a mission to improve the quality of life and living environments, is principally engaged in the research and development and commercialization of health and environment innovations. Leveraging its Multilevel Antimicrobial Polymer (MAP-1) technology, APEL has developed specialized application formulas in four key areas: air purification in aircraft, water purification, livestock health, and eco-friendly building materials, all designed to address pressing global challenges. APEL looks forward to working with researchers and industry partners worldwide to drive further health and environmental innovations.For media enquiries, please contact:Avy YuEudice LawTel: +852 9500 4443Tel: +852 9326 1113Email: avy.yu@ajacapital.com.hkEmail: eudice.law@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年3月10日 - (亞太商訊 via SeaPRwire.com) - 由周大福控股戰略入股的uSMART盈立證券有限公司（下稱「盈立證券/ 本公司」）欣然宣佈將在落馬洲港鐵站及西九龍高鐵站開設兩家新分行。受近期港股熾熱投資氣氛帶動，過去1年內，香港本地註册用戶較去年同期增長300%。為提供更便捷及優質的客戶體驗，盈立證券決定在九龍和新界設立新分行，以滿足不同地區客戶的需求，進一步擴大客戶基礎。近期中國『十大科技股』十分火熱，表現媲美美國『神奇七股』，市場估值亦具有吸引力，因此吸引不少投資者的關注。這股投資熱潮使本公司的開戶需求大幅上升，我們預期這勢頭將會持續，並看好未來股市投資環境。因此，盈立證券決定抓緊這個發展機遇，同時開設兩間新分行，提升市場競爭力。 作為首家在港鐵站內設立分行之券商，這不僅是一次創新突破，更是品牌發展中的重要里程碑。為方便客戶，我們特選在這兩個交通熱點開設分行，預計將於 2025 年中隆重開幕，並實施每星期7天營業服務。客戶可在分行面對面與投資顧問進行一般查詢、辦理開戶及諮詢投資理財等事宜。如遇到任何使用流動交易程式時的疑問，客戶亦可亦可親臨分行體驗查詢。西九龍高鐵站分行初步效果圖為慶祝兩家分行即將投入服務，uSMART盈立證券將於4月推出「ATM三巨頭」 (騰訊、阿里巴巴、美團) 免佣 及 免平台費 優惠，惠及所有持有uSMART盈立證券賬戶的客戶。此外，本公司亦歡迎客戶提議心水港股，並將於第三季根據客戶的反饋調整，相信這將為客戶創造更可觀的收益。 為回饋忠實客戶多年的支持，uSMART盈立證券亦同時提供多項 真全免 優惠，包括：1)100隻港股ETF 0佣 0平台費；2)月供美股、港股0佣 0平台費 0存倉費無論新客戶及現有客戶，都可以享受真全免，絕無取巧，我們設計以上優惠，旨在滿足短線、中線及長線投資策略，讓持有uSMART盈立證券賬戶的客戶均能受益。隨著全球股市交投活躍，過去1年內，盈立證券（新加坡）的註册用戶數量較去年同期驟升8倍。最近uSMART盈立集團的全資子公司uSMART Capital,LLC 正式獲批美國 FINRA券商牌照，這標誌著集團在全球金融市場的戰略佈局取得了重大進展。展望未來，uSMART盈立證券將繼續以科技賦能金融，致力於為全球客戶創造更多價值，並推動金融服務的創新與升級。關於uSMART盈立證券：由周大福控股戰略入股的盈立證券是一間領先科技港資券商，成立於2018年，7年來憑藉卓越的戰略規劃和創新能力，致力於將科技與金融深度融合，業務範圍涵蓋證券、資產管理、財富管理等領域，為全球投資者獨家研發了金融證券交易平台 uSMART HK APP和uSMART SG APP，分別由盈立證券（香港）和盈立證券（新加坡）提供服務。集團APP支持港股、美股、A股（滬深港通）、新加坡股票、日本股票、英國股票、美股期權、ETF、基金、債券、資管、結構化票據、期貨、加密貨幣、貴金屬、黃金和外匯等多元化的投資交易服務，此外更為超高淨值個人與家族、企業提供度身訂制服務，打造全方位綜合性資產管理解決方案。 詳情可瀏覽 www.usmart.hk/zh-hk傳媒查詢：黃曉霖 Carrie Wong9788 4665carriewong@usmart.hk Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Mar 10, 2025 - (ACN Newswire via SeaPRwire.com) - uSmart Securities Limited (referred to as "uSMART Securities/ the Company"), strategic investments from Chow Tai Fook Holding , is pleased to announce the opening of two new branches at Lok Ma Chau MTR Station and Hong Kong West Kowloon High Speed Rail Station. Driven by the recent surge in Hong Kong stock market, during the past year, the Company’s local registered user in Hong Kong has increased by 300% compared to the same period last year. To provide a more convenient and high-quality customer experience, uSMART Securities has decided to expand its presence in Kowloon and the New Territories, catering to clients across regions and further broadening its customer base.Recently, China's "Top Ten Technology Stocks" have been performing exceptionally well, rivaling the popularity of the U.S. "Magnificent Seven," and their market valuations remain attractive, drawing significant attention from investors. This investment boom has led to a sharp rise in account opening demand at the Company with expectations of sustained momentum amid favorable market conditions. The Company aims to capitalize on this growth opportunity by simultaneously launching two new branches to strengthen its competitive edge.As the first brokerage to establish branches in MTR stations, this move represents not only an innovative breakthrough but also a significant milestone in the brand's development. To better serve customers, we have strategically chosen these two transportation hubs, which are expected to officially open in mid-2025 and operate seven days a week. Clients can access in-person consultations, account opening services, and investment advisory support, as well as investment planning. If you have any questions while using the uSMART APP, please visit the branch for hands-on assistance.West Kowloon High Speed Rail Station Branch Preliminary RenderingsTo celebrate the upcoming launch of the two new branches, uSMART Securities will introduce a special promotion in April offering 0 commissions and 0 platform fees for trading the “ATM Trio” (Tencent, Alibaba, Meituan) for all account holders. Additionally, the Company welcomes clients to suggest their favorite Hong Kong stocks for promotion offer. Based on these suggestions, we will make adjustments in the third quarter, aiming to deliver even more substantial returns for our clients.To express gratitude for the unwavering support of our valued clients, uSMART Securities is pleased to introduce a series of commission-free offerings, including:1）Invest in 100 Hong Kong Stock ETFs with 0 Commission, 0 Platform Fees* ;2）0 Commission, 0 Platform Fees, and  0 Custody Fees for U.S. and Hong Kong Monthly Investment PlanBoth new and existing clients can enjoy the offers without any hidden clauses. We have designed these promotions to cater to short-term, medium-term, and long-term investment strategies, ensuring that all uSMART Securities clients can benefit.Amid heightened global market activity, during the past year, the number of registered users at uSMART Singapore has surged eightfold year-on-year, demonstrating its robust growth momentum. Simultaneously, uSMART Capital, LLC, a wholly-owned subsidiary of uSMART Group, has officially obtained a brokerage license from the U.S. Financial Industry Regulatory Authority (FINRA), marking a significant milestone in the Group's strategic expansion into global financial markets. Looking ahead, uSMART Securities will continue to leverage technology to drive financial innovation, delivering greater value to clients worldwide.About uSmart Securities LimiteduSmart Securities Limited, a leading tech broker in Hong Kong backed by Chow Tai Fook Holdings, was founded in 2018. Over the past seven years, the Company has pioneered the integration of technology and finance, offering securities, asset management, and wealth management services. To serve global investors, uSMART has exclusively developed the financial trading platforms uSMART HK APP and uSMART SG APP, operated by uSMART Hong Kong and uSMART Singapore, respectively. The Group's APPs support diversified investment and trading services, including Hong Kong stocks, U.S. stocks, A-shares (Stock Connect), Singapore stocks, Japan stocks, U.K. stocks, U.S. options, ETFs, funds, bonds, asset management, structured notes, futures, cryptocurrencies, precious metals, gold, and forex. The Group also offers tailored services for ultra-high-net-worth individuals, families, and enterprises, providing comprehensive and integrated asset management solutions to meet diverse wealth management needs.Learn more: www.usmart.hk/enFor any media queries, please contact:Carrie Wong9788 4665carriewong@usmart.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

- 香港國際珠寶展於昨天圓滿閉幕，香港國際鑽石、寶石及珍珠展亦於上周四結束- 兩展共吸引來自141個國家及地區、逾82,000名買家親臨採購，展示香港商貿平台的國際影響力- 東盟、中東、西歐和南美買家均見增長- 現場問卷調查結果顯示，買家及展商認為未來兩年珠寶產品於中東市場的增長潛力最大- 逾四成受訪者預計未來一至兩年整體銷售額將會上升，逾五成受訪者預計持平香港, 2025年3月9日 - (亞太商訊 via SeaPRwire.com) - 由香港貿易發展局（香港貿發局）主辦的第41屆香港國際珠寶展以及第11屆香港國際鑽石、寶石及珍珠展，繼續採用「兩展兩地」模式，雲集來自逾40個國家及地區、約4,000家展商參與。珠寶展昨天於香港會議展覽中心圓滿閉幕，而鑽石、寶石及珍珠展已於上周四在亞洲國際博覽館結束。今屆珠寶展首次增設「黃金首飾」展區，蒐羅設計新穎的金飾，以及「新晉珠寶設計師」專區，展示設計新秀的潛力，幫助業界把握新機遇。珠寶雙展共吸引來自141個國家及地區、逾82,000名買家親臨採購，其中有來自125個國家及地區約32,000名買家參與鑽石、寶石及珍珠展，以及來自133個國家及地區約51,000名買家出席珠寶展，東盟、中東、西歐和南美買家均錄得增長，充分彰顯珠寶雙展的國際化。香港貿發局副總裁張淑芬表示：「作為全球領先的珠寶商貿平台，珠寶雙展聯結全球買家，並舉辦超過30場行業講座及活動，推動業界創新及交流，同時積極透過珠寶設計比賽推廣本地設計及發掘業界新秀，展示珠寶雙展於國際珠寶業界的影響力，以及香港作為世界一流會展中心的地位。」展商及買家最看好中東市場為更深入了解珠寶行業趨勢，香港貿發局對現場1,434名參展商和買家進行問卷調查。結果發現買家及展商對經濟前景的態度審慎樂觀，問卷調查重點結果如下：市場及行業展望：44.2%受訪者預計未來一至兩年整體銷售額將會上升，50.6%受訪者預計持平。受訪者認為未來兩年珠寶產品於以下目標銷售市場的增長前景為理想及非常理想：中東（76.8%）、印度（72.6%）、澳洲及太平洋群島（67.8%）、東盟（66.2%）、韓國（66%）。市場潛力方面，最多受訪者正在嘗試開拓的市場分別是歐洲（24.9%）、東盟（15.2%）、北美洲（13.4%）、中東（11.4%）、日本（7.9%）。未來三年，人工智能（62.8%）、大數據（46.9%），以及社交媒體（44.6）的技術進步對珠寶行業影響最大。產品趨勢：受訪者認為今年時尚首飾（61.9%）、貴重珠寶（39.1%）、輕奢首飾（24.4%）有最大增長潛力。黃色K金（43.4%）、白色K金（37.8%）及純黃金（28.6%）是2025年最受歡迎的貴金屬產品。鑽石（47.6%）是今年最受歡迎的寶石，其次是紅寶石（26.2%）、祖母綠（19.1%）。香港貿發局呼應最新公布的政府財政預算案，協助本地企業開拓內地市場及增加電商銷售。今年淘寶天貓首次參與珠寶展，助展商突破地域界限，開拓內地市場，共有10間參展商及六位網紅達人參與，總觸及高達超過600萬人次，銷售額達5,000萬港元。參展商稱銷售額超預期珠寶雙展廣受全球業內人士喜愛，有展商反映銷售喜出望外。在珠寶展，帶來九個設計師的香港展商亞洲珠寶文化設計工藝協會創會會長鄭陳曼芝說：「我們希望透過這次展會接觸中東買家，並開拓新的國際市場，期望銷售額達100萬至300萬美元。」香港展商新世界海達有限公司董事長張海達亦稱今年接觸到俄羅斯、韓國及中國內地客戶，在展會的銷售表現較去年升三倍。在鑽石、寶石及珍珠展，德國展商HC Arnoldi e.K.行政總裁Carl Philip Arnoldi表示：「展會最大優勢之一是吸引全球製造商及買家參與，參展首天已接觸到許多中東和亞洲的客戶，我們預計今年銷售將有20%至50%的升幅。」另有展商表示通過展會不但接觸到美國大型零售業優質買家，亦找到新興市場如印尼、菲律賓及越南等具潛力的合作夥伴，又見許多買家重臨採購。同時，部份中國內地、中東、美國及馬來西亞的買家預計在珠寶雙展斥資數十萬至上百萬美元採購。在珠寶展，來自中國內地的湖南省彩度珠寶貿易有限公司已訂購價值超過40萬美元的高品質澳洲珍珠；來自阿聯酋的Kanz Jewels LLC已預算25 萬美元作採購之用；黎巴嫩買家Michel Zoughaib稱讚展會提供一站式平台，可採購不同設計的產品，甚至珠寶技術及包裝，預算花費100萬美元，「如覓得合適的供應商，我可把預算提高至約1,500萬美元。」美國買家David Levy Diamond Inc.總裁David Levy亦稱，在展會不但可聯繫生產商，也能接觸供應鏈中不同類型的企業，只需來香港珠寶雙展便可覓得所需一切，「相信會在鑽石、寶石及珍珠展花費20萬美元，在珠寶展預料最少花費25萬美元。」另外，有來自東盟市場買家採購態度積極，例如馬來西亞多美集團預算花費10至20萬美元採購。提升穆斯林友善採購體驗配套今年大會為鼓勵穆斯林買家來港採購，特別加強穆斯林友善措施，包括會場設祈禱室、提供接駁巴士往返清真寺、提供穆斯林友善酒店和餐廳名單、並與香港旅發局合作提供特色導賞團等，鼓勵穆斯林買家來港採購。作為全球領先的一站式珠寶業採購平台，今年珠寶雙展繼續沿用「展覽+」（EXHIBITION+）線上線下融合模式，讓企業延伸實體展中的洽商至網上智能配對平台。當中「商對易」（Click2Match）的人工智能會為展商及買家提供線上商貿配對。在場買家則可利用「掃碼易」（Scan2Match）掃描展商的二維碼，於展會期間或之後隨時隨地於線上洽談。買家亦可以通過「香港貿發局商貿平台」流動應用程式（HKTDC Marketplace App）及兩展的官方網頁，預先完成登記及認證買家證，大大提升進場及採購效率。圖片下載：https://bit.ly/3XyhcAc由香港貿發局主辦的第41屆香港國際珠寶展，以及第11屆香港國際鑽石、寶石及珍珠展圓滿結束。珠寶雙展廣受全球業內人士喜愛，買家採購態度積極。財經事務及庫務局常任秘書長（財經事務）甄美薇（右五）擔任珠寶交流酒會的主禮嘉賓，酒會接待來自海內外的珠寶業界代表、買家等，促進業界的交流合作。珠寶匯演展示最新創意設計，促進各方交流。淘寶天貓參與珠寶展，助展商突破地域界限，開拓內地市場。珠寶展增設「黃金首飾」展區，展示設計新穎的金飾。珠寶雙展設38個展館，其中亞洲珠寶文化設計工藝協會首度參展。此外，珠寶展今年新增「新晉珠寶設計師」專區，展示新生代設計師的創意及工藝。珠寶雙展期間舉行超過30場珠寶行業講座及交流活動。相關網頁 香港國際珠寶展香港國際鑽石、寶石及珍珠展展覽網頁http://hkjewelleryshow.hktdc.com/tchttp://hkdgp.hktdc.com/tc精選產品https://bit.ly/4hE1ifz香港貿發局新聞中心：http://mediaroom.hktdc.com/tc傳媒查詢香港貿易發展局傳訊及公共事務部：夏妙婷電話：(852) 2584 4575電郵：sharon.mt.ha@hktdc.org張希汶電話：(852) 2584 4272電郵：serena.hm.cheung@hktdc.org劉茸電話：(852) 2584 4472電郵：clayton.y.lawuw@hktdc.org香港貿易發展局簡介香港貿易發展局(香港貿發局)是於1966年成立的法定機構，負責促進、協助和發展香港貿易。香港貿發局在世界各地設有超過50個辦事處，其中13個設於中國內地，致力推廣本港作為雙向環球投資及商業樞紐。 香港貿發局通過舉辦國際展覽會、會議及商貿考察團，為企業(尤其是中小企)開拓內地和環球市場的機遇。香港貿發局亦通過研究報告和數碼資訊平台，提供最新的市場分析和產品資訊。有關香港貿發局的其他資訊，請瀏覽www.hktdc.com/aboutus/tc。 Copyright 2025 亞太商訊 via SeaPRwire.com.

- The Hong Kong International Jewellery Show drew to a successful close yesterday while the Hong Kong International Diamond, Gem & Pearl Show ended on Thursday- The twin shows attracted over 82,000 buyers from 141 countries and regions, illustrating Hong Kong’s international influence as a trading platform for the industry- There was an increase in the number of buyers from ASEAN, Middle East, Western Europe and North America.- An on-site survey revealed that buyers and exhibitors considered the Middle East market to hold the greatest potential for growth in the jewellery industry over the next two years- Over 40% of respondents expected overall sales to increase in the next one to two years, with more than 50% anticipating stabilityHONG KONG, Mar 9, 2025 - (ACN Newswire via SeaPRwire.com) - The 41st Hong Kong International Jewellery Show and 11th Hong Kong International Diamond, Gem & Pearl Show, organised by the Hong Kong Trade Development Council (HKTDC), attracted some 4,000 exhibitors from more than 40 countries and regions, running in the successful “two shows, two venues” format. The Jewellery Show concluded at the Hong Kong Convention and Exhibition Centre (HKCEC) yesterday while the Diamond, Gem & Pearl Show closed at AsiaWorld-Expo on Thursday. This year’s International Jewellery Show introduced the Gold Jewellery zone, showcasing unique designs and exquisitely crafted gold jewellery, and the Young Jewellery Designer Arena, highlighting the potential of emerging designers, helping the industry to capture new opportunities.The twin jewellery shows attracted over 82,000 buyers from 141 countries and regions. Among them, some 32,000 buyers from 125 countries and regions participated in the Diamond, Gem & Pearl Show, while about 51,000 buyers from 133 countries and regions attended the International Jewellery Show. There was an increase in the number of buyers from ASEAN, the Middle East, Western Europe and North America, highlighting the international appeal of the shows.Sophia Chong, Deputy Executive Director of the HKTDC, said: “As a leading global trading hub for the jewellery industry, the twin jewellery shows brought together international buyers and organised more than 30 industry seminars and activities to foster innovation and collaboration within the sector. The shows also actively promote local design and nurture the next generation of industry talents through jewellery design competitions, underscoring their impact on the global jewellery landscape and reinforcing Hong Kong's status as a world-class convention and exhibition centre."Exhibitors and buyers are most optimistic about the Middle East marketTo gain deeper insights into current and upcoming trends in the jewellery industry, the HKTDC conducted a survey among 1,434 exhibitors and buyers on-site. The results revealed that buyers and exhibitors are cautiously optimistic on the industry outlook. Key findings from the survey are as follows:Market and industry outlook      44.2% of respondents expected overall sales to increase in the next one to two years, with 50.6% anticipating stability.Respondents considered the growth prospects for jewellery products in the following target sales markets to be optimistic and very optimistic in the next two years: Middle East (76.8%), India (72.6%), Australia and Pacific Islands (67.8%), ASEAN (66.2%) and Korea (66.0%).In terms of market potential, the top markets most respondents wished to enter or develop were Europe (24.9%), ASEAN (15.2%), North America (13.4%), Middle East (11.4%) and Japan (7.9%).Looking ahead for the next three years, technological advancements in artificial intelligence (62.8%), big data (46.9%) and social media (44.6%) were anticipated to have the greatest impact on the jewellery industry.Product trendsRespondents believed that trendy fashion jewellery (61.9%), precious jewellery (39.1%) and demi fine jewellery (24.4%) have the greatest growth potential this year.Karat yellow gold (43.4%), karat white gold (37.8%) and pure gold (28.6%) will be the most popular precious metal products in 2025.Diamond (47.6%) will be the most in-demand gemstone, followed by ruby (26.2%) and emerald (19.1%).Echoing measures in the latest Government Budget, the twin jewellery shows continue exploring ways to facilitate local businesses expanding into the Mainland Chinese market and to seize e-commerce opportunities. This year, mainland e-commerce platforms Taobao and Tmall joined the International Jewellery Show the first time, helping exhibitors to enter the mainland market via live e-commerce. With 10 exhibitors and six KOLs participating, the event achieved a total reach of over 6 million people and generated sales of more than HK$50 million.Exhibitors reported sales exceeded expectationsThe twin jewellery shows are widely respected by the global industry, with happy exhibitors reporting that their sales exceeded expectations in 2025. Bringing together nine designers at the International Jewellery Show, the chairman of the Asia Jewelry Culture Design and Crafts Association in Hong Kong, Gigi Cheng, said: “We hope to connect with buyers from the Middle East through the show and explore new international markets, aiming for sales of US$1 million to $3 million.” Hong Kong exhibitor Hatta Chang, Chairman of Hatta New Company, stated that the company successfully connected to buyers from Russia, Korea and Mainland China with sales tripling compared to last year.   At the Hong Kong International Diamond, Gem & Pearl Show, Carl Philip Arnoldi, CEO of German exhibitor HC Arnoldi e.K, said: “One of the show’s biggest advantages is its ability to attract manufacturers and buyers from around the globe. On the first day, we received many buyers from the Middle East and Asia. We anticipate a sales growth of 20% to 50% this year.” Another exhibitor pointed out that the shows not only connected them with major retailers in the United States, but also potential partners in emerging markets such as Indonesia, the Philippines, Vietnam, and more. He also met a lot of return buyers sourcing at the shows.Additionally, buyers from Mainland China, the Middle East, the United States and Malaysia anticipated to invest sums of up to US$1 million in sourcing at the twin jewellery shows. At the International Jewellery Show, Hunan Caidu Jewelry Trading Co., Ltd from Mainland China placed an order of more than US$400,000 for high-quality pearls from Australia. Kanz Jewels LLC from the UAE budgeted to place an order worth US$250,000. Lebanese buyer Michel Zoughaib praised the show as a one-stop platform for sourcing products with different designs, as well as jewellery technology and packaging. He came with a budget of US$1 million but, “If I can find the right supplier, I can spend up to US$15 million,” he said.David Levy, President of David Levy Diamond Inc. in the United States, stated that the shows not only enabled connections with manufacturers but also provided access to different types of businesses within the supply chain. He believed that by attending the Hong Kong twin jewellery shows, he could find everything he needed. “I expect to spend US$200,000 at the Diamond, Gem & Pearl Show and at least US$250,000 at the Jewellery Show,” he said. The sourcing dynamic of buyers from the ASEAN market was noticeably vibrant, with Tomei Gold and Jewelry Manufacturing SDN BHD from Malaysia saying it had allocated a procurement budget of US$100,000 to $200,000.Enhancing support for a Muslim-friendly sourcing experienceThis year, special measures were introduced to encourage more Muslim buyers to visit the shows, including providing prayer rooms in venues, running shuttle buses to and from local mosques, offering a list of Muslim-friendly hotels and restaurants, and cooperating with the Hong Kong Tourism Board to arrange guided tours.As a globally leading one-stop jewellery industry sourcing platform, this year's twin jewellery shows continue to adopt the EXHIBITION+ online and offline hybrid format, enabling enterprises to extend their physical exhibition negotiations to online matching platforms. The HKTDC’s AI-powered Click2Match provided online business matching for exhibitors and buyers, while buyers were able to use Scan2Match to scan exhibitors’ QR codes and continue discussions with exhibitors online during or after the show. Buyers could enhance their efficiency by completing registration and buyer verification in advance through the HKTDC Marketplace App and the official show websites.Photo download: https://bit.ly/3XyhcAcOrganised by the HKTDC, the 41st Hong Kong International Jewellery Show and 11th Hong Kong International Diamond, Gem & Pearl Show have concluded successfullyThe twin jewellery shows are widely respected by the global industry and the sourcing dynamic of buyers was noticeably vibrant this yearSalina Yan, Permanent Secretary for Financial Services and the Treasury (Financial Services) of the Hong Kong SAR Government (fifth right), was Guest of Honour at the jewellery networking reception to welcome representatives and buyers from both local and international sectors with the goal of enhancing collaboration and fostering exchange within the industryThe jewellery parades showcased cutting-edge creative designs and enhanced interaction among industry stakeholdersThe participation of Taobao and Tmall at the International Jewellery Show helped exhibitors to broaden their reach in the Mainland China marketThe International Jewellery Show introduced the Gold Jewellery zone this year, showcasing innovatively designed gold jewelleryThe twin jewellery shows featured 38 pavilions with the Asia Jewellery Culture Design and Crafts Association Limited participating for the first time. In addition, the Young Jewellery Designer Arena was unveiled at this year’s International Jewellery Show, highlighting the creativity and craftsmanship of up-and-coming designersOver 30 industry seminars and networking events were held during the twin jewellery showsWebsites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem & Pearl ShowWebsitehttps://www.hktdc.com/event/hkjewellery/enhttps://www.hktdc.com/event/hkdgp/enSelected productshttps://bit.ly/4hE1ifzHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact HKTDC’s Communication & Public Affairs Department:  Sharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgSerena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lawuw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. Copyright 2025 ACN Newswire via SeaPRwire.com.

Results Highlights:- Revenue hit record high of US$164.1 million, up 6.6% year-on-year.- Sales volume reached 1.7 million units, of which 1.5 million units were proprietary products, showing an increase of 4.8% year-on-year.- Gross profit increased by 7.5% to US$114.5 million, with gross profit margin improving to 69.8%; profit for the year attributable to owners of the Company was US$39.7 million.- The Board proposed a final dividend of HK10 cents per share, representing a dividend payout ratio of 26.7%.- The Group maintained a sound financial position with cash and bank balances of US$248.6 million at year-end to support merger and acquisition initiatives.- Fueled by newly acquired distributors in Indonesia and South Korea, along with organic growth in direct sales, APAC market revenue grew 43.7% year-on-year, while the US and the PRC markets showed signs of recovery in the second half of 2024.- The Group registered products of eucatech AG, a German company acquired in November 2023, in the Czech Republic, Italy, Malaysia, Saudi Arabia, Spain, Switzerland, UAE, and Vietnam.HONG KONG, Mar 7, 2025 - (ACN Newswire via SeaPRwire.com) - OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures, today announced its annual results for the year ended December 31, 2024 (the “Year”), reporting record-high revenue and healthy net profit despite the challenging business landscape.Driven by the recovery of sales in the US and continued growth in the APAC market in the second half of the year, the Group’s revenue reached US$164.1 million, an increase of 6.6% over the previous year. Excluding the impact of foreign exchange, revenue growth would have been 8.7% year-on-year. Gross profit increased by 7.5% to US$114.5 million, and gross profit margin rose slightly to 69.8%. During the Year, the Group laid the groundwork for stronger long-term performance by integrating the businesses of the three companies acquired in late 2023. Although these integration efforts incurred temporary costs, resulting in a profit of US$39.7 million attributable to the owners of the Company (2023: US$45.1 million), they are expected to generate substantial synergies in the future. Excluding the abovementioned additional expenses, the three core operating expenses, namely selling and distribution expenses, general and administrative expenses and research and development expenses, were remained stable year-on-year.As of December 31, 2024, the Group was in a strong financial position with cash and bank balances amounting to US$248.6 million (2023: US$255.8 million). After careful consideration of the Group’s future capital requirements, the Board has proposed a final cash dividend of HK10 cents per share (2023: HK10 cents per share) as a token of appreciation for the continued support from shareholders and investors.Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, said, “In 2024, the OrbusNeich team navigated challenges while diligently strengthening R&D, production, supply chain, clinical, regulatory, quality, sales, and marketing capabilities. The immediate contributions of our newly acquired distributors in Indonesia and South Korea bolstered our APAC market performance. Meanwhile, our focus on product registration for eucatech AG, has resulted in approvals in eight countries, with more on the horizon. As we celebrate OrbusNeich’s 25th anniversary in 2025, our relentless innovation, strong global presence and pioneering products will continue to propel us to new heights, as evidenced by our established global reputation and continued revenue growth over the past few years. Looking ahead, we remain committed to improving patient outcomes while striving to create long-term value for shareholders.”Extensive Sales Network Fuels Growth in APAC and EMEAOrbusNeich sold its products through its extensive sales network covering more than 70 countries and regions worldwide, and maintained a balanced revenue distribution across major markets. Driven by external growth from newly acquired distributors in Indonesia and South Korea, as well as robust organic growth from the markets in Malaysia, Singapore, Hong Kong, Vietnam, and India, the APAC market became the Group’s major growth driver during the Year, with revenue increasing by 43.7% to US$52.2 million. In particular, the latest generation of scoring balloon, Scoreflex TRIO, recorded rapid sales growth following its launch in Malaysia in early 2024. EMEA market revenue grew by 7.9% year-on-year to $39.2 million, mainly attributable to increased sales of the Group’s proprietary balloon products in direct sales markets such as Germany and Spain, as well as in distribution markets such as the Czech Republic, Slovakia, and the United Kingdom.Both the PRC and the US markets achieved significant improvement in the second half of 2024. As the Beijing-Tianjin-Hebei “3+N” Alliance Volume-Based Procurement (“VBP”) was gradually rolled out in various provinces, the Group adopted a more proactive marketing strategy, which resulted in Scoreflex’s sales volume gaining momentum, facilitating an improvement in the performance of the PRC market in the second half of the year, reaching a revenue of US$20.7 million. Meanwhile, following active discussions with Abbott, the Group’s US distributor, revenue in the US gradually picked up. In particular, the sales volume of the high selling price product, Scoreflex NC, more than tripled in the second half of the year compared with the first half, driving the revenue of the US market to reach US$17.5 million. The Japan market recorded revenue of US34.4 million.Diversity in Innovation with a Portfolio of Approved Products and Upcoming Clinical TrialsAs of December 31, 2024, OrbusNeich had more than 240 granted patents and published patent applications worldwide in key jurisdictions and an aggregate of more than 50 approved products. During 2024, the Group made significant progress in terms of product registrations and clinical trials, including:- Obtained NMPA approval for Teleport Neuro, FDA approval for Teleport XT, JADE PLUS 14/18/35 OTW, Sapphire Ultra and Sapphire NC Ultra, and CE Marks for Sapphire Ultra, Sapphire NC Ultra, Xtenza and Teleport XT;- Submitted NMPA registration application for its guiding catheter and Jade PTA Line Extension, and PMDA registration application for Scoreflex QUAD and Teleport Glide;- Completed clinical trial patient enrollment for Scoreflex TRIO in the PRC with NMPA application submission in January 2025;- Initiated clinical trial patient enrollment for Sapphire 3 in the US in Q4 2024, with approval application expected to submitted in Q1 2026.The Group has also been actively registering eucaLimus (DES), Support C (coronary DCB), and VITUS (peripheral DCB) in various countries following the acquisition of eucatech AG in late 2023. Registrations for one or more of the above-mentioned products were completed in the Czech Republic, Italy, Malaysia, SaudiArabia, Spain, Switzerland, the UAE, and Vietnam, while applications are pending approval in Hong Kong, Indonesia, and Singapore. Additionally, to renew the CE Mark for its products under the MDR regime, clinical registries have been initiated with renowned key opinion leader clinicians as lead principal investigators.The Group continued to invest in new pipeline products such as the aspiration catheter, dual lumen catheter, peripheral scoring balloon and sheath, and registration of these products is expected to be submitted to various regulatory bodies in 2025. In line with the “leave nothing behind” trend, the Group is also investing in proprietary paclitaxel DCB, with clinical trials expected to commence in the fourth quarter of 2025 in Japan.During the year, the joint venture OrbusNeich P&F made significant efforts to advance the clinical studies of TricValve in two major APAC markets. The clinical trial in the PRC started in April 2024, while the PMDA clinical trial protocol approval in Japan is expected to be completed by the end of 2025.In addition to proprietary products, the Group also entered into a distribution agreement with a Chinese manufacturer to distribute its intravascular ultrasound (IVUS) catheter in Hong Kong and Macau from December 2024, thereby diversifying its product offerings.Exceptional Product Quality Ensured through Stringent Production ProcessesAs of December 2024, OrbusNeich’s annual production capacity reached approximately 2.0 million units of balloons and 60,000 units of stents, with product quality ensured by a strict management system and maintaining ISO 13485 certification. Notably, eucatech AG successfully passed its ISO 13485 re-certification audit in the latter half of 2024, while the Shenzhen site achieved ISO 14001 and ISO 45001 certifications in June 2024, highlighting its commitment to sustainability.In addition, the construction of the Group’s largest R&D and production facility in Hangzhou, PRC, progressed smoothly during the Year. The Group is currently focusing on enhancing its automation levels to reduce labor requirements, improve operational efficiency, and ultimately lower overall operating costs. The facility is expected to be operational in 2027 and will add an annual production capacity of 2.4 million units upon the commencement of production.Mr. Chien concluded, “Entering 2025, we are cautiously optimistic about our prospects given the strong growth momentum in APAC and EMEA, as well as the recovering US and PRC markets. Over the past 25 years, our success has been fueled by continuous innovation, product line expansion and a strengthened sales network. These efforts, together with the synergies from the integration of our acquired businesses, will position us well to capitalize on the opportunities that lie ahead. With robust financial resources, we are able to take advantage of industry consolidation for strategic mergers and acquisitions to enhance our technological reserves and expand our product portfolio. To maintain our steady growth in the medical device market, we will place greater emphasis on sustainable development to adapt to the evolving healthcare landscape while staying true to our mission of improving patient outcomes.”About OrbusNeich Medical Group Holdings LimitedOrbusNeich is a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into neuro vascular intervention and structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies.For more information, please visit the Group’s official website: https://orbusneich.com/. Copyright 2025 ACN Newswire via SeaPRwire.com.